Fig. 1From: MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitorsComparison between MET amplification identified by FISH and NGS. a Consistency between MET amplification identified by FISH and NGS. b PR rate in group between MET amplification and MET non-amplification identified by different methods. ***P value  < 0.001, ns no significanceBack to article page